Results 291 to 300 of about 31,538 (351)
Some of the next articles are maybe not open access.
Dental Clinics of North America, 2011
Hemostasis is an integral and very important aspect of surgical practice. As a rule, most bleeding from dental surgery can be controlled by pressure. When the application of pressure does not yield satisfactory results, or where more effective hemostasis is required, hemostatic agents are used.
Orrett E, Ogle +2 more
openaire +2 more sources
Hemostasis is an integral and very important aspect of surgical practice. As a rule, most bleeding from dental surgery can be controlled by pressure. When the application of pressure does not yield satisfactory results, or where more effective hemostasis is required, hemostatic agents are used.
Orrett E, Ogle +2 more
openaire +2 more sources
Seminars in Thrombosis and Hemostasis, 2015
The mainstay of treatment of inherited coagulation disorders is based on the infusion of the deficient clotting factor, when available. Significant advances have been made over the past two decades in the production and availability of factor replacement products.
Franchini, Massimo +2 more
openaire +3 more sources
The mainstay of treatment of inherited coagulation disorders is based on the infusion of the deficient clotting factor, when available. Significant advances have been made over the past two decades in the production and availability of factor replacement products.
Franchini, Massimo +2 more
openaire +3 more sources
Topical Hemostatic Agents: A Review
Dermatologic Surgery, 2008Topical hemostatic agents play an important role in both common and specialized dermatologic procedures. These agents can be classified based on their mechanism of action and include physical or mechanical agents, caustic agents, biologic physical agents, and physiologic agents.
Melanie D, Palm, Jeffrey S, Altman
openaire +2 more sources
Oral and Maxillofacial Surgery Clinics of North America, 2016
Nessuno
Bellantone, Rocco Domenico Alfonso +4 more
+5 more sources
Nessuno
Bellantone, Rocco Domenico Alfonso +4 more
+5 more sources
Hemostatic Agents in Orthopedic Surgery
HSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery, 2022Controlling blood loss is a crucial aspect of orthopedic surgery. Hemostatic agents can be used intraoperatively in combination with antifibrinolytics as part of an overall strategy to limit blood loss. Several new hemostatic agents have recently come to the market designed specifically for vascular surgery but have found uses in other surgical fields,
Kira K. Tanghe +7 more
openaire +2 more sources
Transfusion-sparing hemostatic agents
Current Opinion in Hematology, 2002A variety of agents are available to improve hemostasis and reduce blood loss in multiple clinical settings. These agents are most commonly used to reduce bleeding when an underlying hemostatic defect is present. Some new agents offer the potential to decrease blood loss even in the absence of an obvious underlying hemostatic defect.
Jason, Chiu +2 more
openaire +2 more sources
American Journal of Health-System Pharmacy, 2006
The pharmacology, clinical efficacy, adverse effects and toxicities, drug interactions, dosage and administration, and safety issues related to the use of absorbable hemostatic agents are reviewed.Absorbable hemostatic agents exert their pharmacologic effects at various points within the coagulation cascade.
openaire +2 more sources
The pharmacology, clinical efficacy, adverse effects and toxicities, drug interactions, dosage and administration, and safety issues related to the use of absorbable hemostatic agents are reviewed.Absorbable hemostatic agents exert their pharmacologic effects at various points within the coagulation cascade.
openaire +2 more sources
Fibrinogen as a Hemostatic Agent
Seminars in Thrombosis and Hemostasis, 2012Coagulation factor I (fibrinogen) plays an essential role in the hemostatic system by bridging activated platelets and being the key substrate for thrombin in establishing a consolidating fibrin network. Fibrinogen is synthesized in the liver and the plasma concentration is 1 to 5-4.0 g/L.
Sørensen, Benny +5 more
openaire +2 more sources
Local hemostatic agent - fluid active hemostatic matrix
Khirurgiya. Zhurnal im. N.I. Pirogova, 2019Uncontrolled surgical bleeding can have significant clinical and economic consequences including advanced medical expenses and impairment of the outcomes. Effective and safe local hemostatic agents based on a fluid active hemostatic matrix are reviewed in the article.
openaire +2 more sources
Hemostatic Agents and Their Safety
Journal of Cardiothoracic and Vascular Anesthesia, 1999The pharmacologic management of hemostasis in patients undergoing cardiopulmonary bypass may be accompanied by adverse responses. Evaluating the safety profile of hemostatic agents (eg, lysine analogs, aprotinin, protamine, or even donor blood) should be done objectively.
openaire +2 more sources